leisure time -WSS

leisure time

author：explore 2025-09-30 18:54:23 - browse：68382

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Cancer researcher Catriona Jamieson is sending tumors into space

WSS

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Morphosys mixed study results for blood cancer drug

Getting Alzheimer's drug Leqembi to patients can be a challenge

UnitedHealth financials solid despite Change Healthcare cyberattack

Morphosys mixed study results for blood cancer drug

After traumatic brain injury, life support decisions can use more time

knowledge

leisure time

Wikipedia

United colonoscopy coverage change 'may cost lives,' doctors say

H5N1 bird flu virus started spreading in cows in Texas in December

Medical records are filled with copy

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

23andMe had bad news about my health. I wish a person had delivered it

Why rehabilitation engineers need to center patients in their research

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Gain of function research would be limited under House proposal

Hollywood unions extend contract negotiations for actors

Gain of function research would be limited under House proposal

Wikipedia

MultiPlan and major insurers sued for alleged medical price

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

H5N1 bird flu virus started spreading in cows in Texas in December

Congress must reauthorize a committee to support older Americans

Readout LOUD podcast: A CRISPR milestone, biotech mixology

U.K. considers world's first use of meningitis vaccine to address gonorrhea

hotspot

hotspot

entertainment

focus